ED-B FN expression on blood vessels in normal lymphatic tissues and lymphatic tissues altered by nonneoplastic disease
| Entity . | Perivascular ED-B FN expression, percentage EB-D+ vessels . | |||
|---|---|---|---|---|
| More than 90% . | 50%-90% . | 10%-50% . | Less than 10% . | |
| Normal lymphoid and hematopoietic tissues | ||||
| Normal lymph nodes | 0/10 | 0/10 | 1/10 | 9/10 |
| Normal bone marrow biopsies | 0/9 | 0/9 | 0/9 | 9/9 |
| Hyperplastic lymphoid tissues | ||||
| Hyperplastic lymph nodes | 5/12 | 6/12 | 0/12 | 1/12 |
| Hyperplastic tonsils | 7/13 | 0/13 | 1/13 | 5/13 |
| Entity . | Perivascular ED-B FN expression, percentage EB-D+ vessels . | |||
|---|---|---|---|---|
| More than 90% . | 50%-90% . | 10%-50% . | Less than 10% . | |
| Normal lymphoid and hematopoietic tissues | ||||
| Normal lymph nodes | 0/10 | 0/10 | 1/10 | 9/10 |
| Normal bone marrow biopsies | 0/9 | 0/9 | 0/9 | 9/9 |
| Hyperplastic lymphoid tissues | ||||
| Hyperplastic lymph nodes | 5/12 | 6/12 | 0/12 | 1/12 |
| Hyperplastic tonsils | 7/13 | 0/13 | 1/13 | 5/13 |
Semiquantitative analysis of ED-B FN expression in normal and inflammatory altered lymphoid tissues. The extent of ED-B expression was classified according to the indicated percentages of ED-B FN–positive vessels.